中国药物警戒 ›› 2025, Vol. 22 ›› Issue (12): 1345-1351.
DOI: 10.19803/j.1672-8629.20250745

• 心脑血管中药作用机制与安全性评价专栏 • 上一篇    下一篇

安宫牛黄丸改善缺血性及出血性中风大鼠氧化应激的神经保护机制研究

李雪丽1, 唐田2△, 白雪1*   

  1. 1中国中医科学院医学实验中心,北京市中医药防治重大疾病基础研究重点实验室,北京 100700;
    2中国科学院北京基因组研究所国家生物信息中心,北京 100101
  • 收稿日期:2025-10-24 发布日期:2025-12-19
  • 通讯作者: *白雪,女,博士,助理研究员,中药防治心脑血管疾病。E-mail: dr.baixue@hotmail.com
  • 作者简介:李雪丽,女,博士,副研究员,中药防治心脑血管疾病。Δ为并列第一作者。
  • 基金资助:
    国家自然科学基金资助项目(82304767、82204670); 中央级公益性科研院所基本科研业务费专项基金(ZZ15-YQ-055、ZZ13-YQ-081、XTCX2023002); 中国中医科学院科技创新工程项目(CI2021B017)

Neuroprotective Mechanisms of Angong Niuhuang Wan for Attenuating Oxidative Stress in Rat Models of Ischemic and Hemorrhagic Stroke

LI Xueli1, TANG Tian, BAI Xue1*   

  1. 1Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing Key Laboratory of Traditional Chinese Medicine Basic Research on Prevention and Treatment of Major Disease, Beijing 100700, China;
    2Beijing Institute of Genomics, Chinese Academy of Sciences/China National Center for Bioinformation, Beijing 100101, China
  • Received:2025-10-24 Published:2025-12-19

摘要: 目的 探讨安宫牛黄丸改善缺血性及出血性中风模型大鼠氧化应激的神经保护机制。方法 采用分子对接与分子动力学模拟技术,分析安宫牛黄丸中关键活性成分与脑源性神经营养因子(BDNF)及神经生长因子(NGF)的相互作用;分别建立脑缺血与脑出血大鼠模型,将动物随机分为假手术组、模型组、安宫牛黄丸低剂量组(257 mg·kg-1)及高剂量组(514 mg·kg-1);通过生化法检测大鼠脑组织中丙二醛(MDA)含量和谷胱甘肽过氧化物酶(GSH-Px)活性;采用Western Blot法检测大鼠脑组织BDNF与NGF蛋白表达水平。结果 分子对接结果显示,安宫牛黄丸中核心成分小檗碱与BDNF、黄芩苷与NGF均表现出良好结合活性,结合能均低于-5.0 kcal·mol-1。分子动力学模拟进一步验证了小檗碱与BDNF、黄芩苷与NGF之间具有稳定的结合特征。动物实验表明,与模型组比较,安宫牛黄丸低剂量组大鼠脑组织中MDA水平显著降低(P<0.05),GSH-Px含量显著升高(P<0.05),BDNF和NGF蛋白表达亦显著上调(P<0.05)。结论 安宫牛黄丸可能通过减轻氧化应激并上调BDNF/NGF通路,在缺血性及出血性中风模型中发挥神经保护作用。

关键词: 安宫牛黄丸, 缺血性中风, 出血性中风, 神经营养因子, 神经生长因子, 抗氧化, 分子对接, 大鼠

Abstract: Objective To investigate the neuroprotective mechanism through which Angong Niuhuang Wan mitigates oxidative stress in rats with ischemic and hemorrhagic stroke. Methods Molecular docking and molecular dynamics simulations were used to analyze the interactions between key active components of Angong Niuhuang Wan and the brain-derived neurotrophic factor (BDNF) and the nerve growth factor (NGF). Rat models of cerebral ischemia and cerebral hemorrhage were established before the animals were randomly divided into sham-operated, model, low-dose Angong Niuhuang Wan (257 mg·kg-1), and high-dose Angong Niuhuang Wan (514 mg·kg-1) groups. Malondialdehyde (MDA) and glutathione peroxidase (GSH-Px) levels in brain tissues were measured using biochemical assays. Protein expression levels of BDNF and NGF were detected by Western blot. Results Molecular docking results showed that the core components of Angong Niuhuang Wan-berberine and baicalin-had good binding activity with BDNF and NGF, respectively, with binding energies below -5.0 kcal·mol-1. Molecular dynamics simulations confirmed stable binding activity between berberine and BDNF, and between baicalin and NGF. Animal experiments suggested that in the low-dose Angong Niuhuang Wan groups, MDA levels were significantly reduced (P<0.05) GSH-Px contents increased (P<0.05) while protein expressions of BDNF and NGF were significantly up-regulated (P<0.05) in brain tissues of rats compared with the model group. Conclusion Angong Niuhuang Wan may exert neuroprotective effects in ischemic and hemorrhagic stroke models by reducing oxidative stress and upregulating the BDNF/NGF pathway.

Key words: Angong Niuhuang Wan, Ischemic Stroke, Hemorrhagic Stroke, Neurotrophic Factor, Nerve Growth Factor, Antioxidant, Molecular Docking, Rat

中图分类号: